GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

TTY Biopharm Co 4105.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

81.30

+2.65%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 6.45bn

FY2016FY2025

Net income

TWD 1.56bn

FY2016FY2025

Free cash flow

TWD 1.61bn

FY2016FY2025

Shareholders' equity

TWD 7.24bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 6.45bnTWD 5.89bnTWD 5.51bnTWD 5.06bnTWD 4.54bnTWD 4.22bnTWD 4.47bnTWD 4.04bnTWD 4.08bnTWD 3.76bn
Gross profitTWD 3.72bnTWD 3.41bnTWD 3.29bnTWD 3.02bnTWD 2.77bnTWD 2.60bnTWD 2.91bnTWD 2.66bnTWD 2.67bnTWD 2.56bn
Research and developmentTWD 194.3mTWD 271.4mTWD 310.4mTWD 353.4mTWD 287.6mTWD 261.6mTWD 298.6mTWD 361.1mTWD 295.7mTWD 341.7m
Operating incomeTWD 1.70bnTWD 1.39bnTWD 1.44bnTWD 1.43bnTWD 1.11bnTWD 1.21bnTWD 1.22bnTWD 1.06bnTWD 1.26bnTWD 1.18bn
Net incomeTWD 1.56bnTWD 1.45bnTWD 1.13bnTWD 1.09bnTWD 831.9mTWD 924.2mTWD 900.1mTWD 1.46bnTWD 1.34bnTWD 1.19bn
Diluted earnings per share6.275.824.534.403.353.723.625.885.414.79

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 11.35bnTWD 10.86bnTWD 9.87bnTWD 9.60bnTWD 9.30bnTWD 9.36bnTWD 9.55bnTWD 9.05bnTWD 9.51bnTWD 9.29bn
Cash and short-term investments——TWD 2.82bnTWD 2.68bnTWD 2.59bnTWD 2.57bn———TWD 3.17bn
Total liabilitiesTWD 3.30bnTWD 3.35bnTWD 3.37bnTWD 3.37bnTWD 3.53bnTWD 3.28bnTWD 3.38bnTWD 2.66bnTWD 3.40bnTWD 3.91bn
Debt—TWD 1.71bnTWD 1.86bnTWD 1.81bnTWD 2.12bnTWD 2.14bnTWD 1.93bnTWD 1.50bnTWD 2.20bnTWD 2.08bn
Shareholders' equityTWD 7.24bnTWD 6.75bnTWD 5.94bnTWD 5.66bnTWD 5.17bnTWD 5.45bnTWD 5.57bnTWD 5.80bnTWD 5.50bnTWD 5.38bn
Shares outstanding249m249m249m249m249m249m249m249m249m249m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 1.76bnTWD 1.35bnTWD 1.09bnTWD 1.24bnTWD 1.26bnTWD 526.4mTWD 1.21bnTWD 1.07bnTWD 996.5mTWD 1.23bn
Capital spending−TWD 150.8m−TWD 134.3m−TWD 99.6m−TWD 135.5m−TWD 74.2m−TWD 181.9m−TWD 69.9m−TWD 74.1m−TWD 96.8m−TWD 103.8m
Free cash flowTWD 1.61bnTWD 1.22bnTWD 985.7mTWD 1.10bnTWD 1.18bnTWD 344.5mTWD 1.14bnTWD 999.7mTWD 899.7mTWD 1.12bn
Dividends paid−TWD 1.04bn−TWD 870.3m−TWD 845.4m−TWD 745.9m−TWD 994.6m−TWD 994.6m−TWD 1.12bn−TWD 1.12bn−TWD 944.9m−TWD 870.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.65bnTWD 1.52bnTWD 1.66bnTWD 1.82bnTWD 1.51bnTWD 1.46bnTWD 1.71bnTWD 1.53bn
Gross profitTWD 969.8mTWD 912.2mTWD 936.8mTWD 1.01bnTWD 887.4mTWD 884.5mTWD 883.0mTWD 951.1m
Operating incomeTWD 491.6mTWD 484.1mTWD 359.1mTWD 527.9mTWD 406.8mTWD 413.1mTWD 343.2mTWD 457.1m
Net incomeTWD 406.4mTWD 443.1mTWD 303.2mTWD 580.2mTWD 284.7mTWD 391.1mTWD 534.5mTWD 372.6m
Diluted earnings per share1.631.781.222.331.141.572.141.50
Cash from operationsTWD 209.0mTWD 654.0mTWD 778.0m—TWD 263.0mTWD 396.0mTWD 801.0mTWD 101.0m
Capital spending−TWD 34.0m−TWD 128.0m−TWD 34.0m—−TWD 23.0m−TWD 41.0m−TWD 57.0m−TWD 30.0m
Free cash flowTWD 175.0mTWD 526.0mTWD 744.0m—TWD 240.0mTWD 355.0mTWD 744.0mTWD 71.0m
Total assetsTWD 11.83bnTWD 11.68bnTWD 11.35bnTWD 11.54bnTWD 10.67bnTWD 10.97bnTWD 10.86bnTWD 10.64bn
Cash and short-term investments———TWD 3.04bn————
DebtTWD 400.0m——TWD 1.61bnTWD 100.0mTWD 100.0mTWD 100.0m—
Shareholders' equityTWD 6.96bnTWD 6.57bnTWD 7.24bnTWD 6.86bnTWD 6.18bnTWD 6.12bnTWD 6.75bnTWD 6.21bn

Financial ratios

Data as of 27 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin57.7%57.9%59.7%59.7%61.0%61.7%
Operating margin26.4%23.6%26.2%28.2%24.5%28.7%
Net margin24.2%24.6%20.5%21.6%18.3%21.9%
Return on equity21.5%21.5%19.0%19.3%16.1%17.0%
Return on assets13.7%13.3%11.4%11.4%8.9%9.9%
Free cash flow yield—7.6%6.1%7.0%6.8%3.6%
Revenue growth9.5%7.1%8.8%11.6%7.4%-5.5%
Earnings growth7.6%28.5%3.1%31.6%-10.0%2.7%
Current ratio2.28x2.02x2.08x1.73x1.56x1.88x
Debt to equity0.00x0.01x0.32x0.33x0.42x0.39x
Equity ratio63.8%62.1%60.2%58.9%55.6%58.2%
Interest coverage44.10x35.98x40.85x61.63x58.64x62.42x
R&D as a share of sales3.0%4.6%5.6%7.0%6.3%6.2%
Buybacks as a share of market value—-0.1%-0.2%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.4%8.9%7.3%
Operating income6.1%7.1%8.0%
Net income12.5%11.0%2.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin57.8%58.7%59.4%62.1%
Operating margin25.1%26.1%26.2%27.0%
Net margin24.4%22.8%22.1%25.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings13.012.517.718.920.618.522.813.018.921.4
Price to sales3.13.13.64.13.84.04.64.76.36.8

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 26 Mar 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year4.504.203.503.403.00
  • 1067-for-1000 split · 13 Aug 2014
  • 1.089-for-1 split · 20 Aug 2013
  • 1.24-for-1 split · 13 Aug 2012
  • 1.234-for-1 split · 29 Jul 2011
  • 1.09-for-1 split · 20 Sept 2010
  • 117-for-100 split · 31 Jul 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.